Stringent screening strategy significantly reduces reactivation rate of Tuberculosis in Patients with Inflammatory Bowel Disease on anti-TNF therapy in a TB endemic region

被引：0

作者：

Kumar, P. ^{[1
]}

Vuyyuru, S. K. ^{[1
]}

Kante, B. ^{[1
]}

Sahu, P. ^{[1
]}

Goyal, S. ^{[1
]}

Madhu, D. ^{[1
]}

Jain, S. ^{[1
]}

Ranjan, M. K. ^{[1
]}

Mundhra, S. ^{[1
]}

Golla, R. ^{[1
]}

Singh, M. ^{[1
]}

Virmani, S. ^{[1
]}

Gupta, A. ^{[1
]}

Yadav, N. ^{[1
]}

Kalaivani, M. ^{[1
]}

Sharma, R. ^{[1
]}

Das, P. ^{[1
]}

Makharia, G. ^{[1
]}

Kedia, S. ^{[1
]}

Ahuja, V. ^{[1
]}

机构：

[1] All India Inst Med Sci, Dept Gastroenterol & Human Nutr, New Delhi, India

来源：

JOURNAL OF CROHNS & COLITIS | 2022年 / 16卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

P531

引用

页码：I484 / I484

页数：1

共 50 条

[11] Tuberculosis infection following anti-TNF therapy in inflammatory bowel disease, despite negative screening
Debeuckelaere, Celine
De Munter, Paul
Van Bleyenbergh, Pascal
De Weyer, Walter
Van Assche, Gert
Rutgeerts, Paul
Vermeire, Severine
JOURNAL OF CROHNS & COLITIS, 2014, 8 (06): : 550 - 557
[12] ACTIVE TUBERCULOSIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE AFTER TREATMENT WITH ANTI-TNF THERAPY
Owen, L.
Thi, A. A.
Bouri, S.
Wolfson, P.
Abbara, A.
John, L.
Davidson, R. N.
Hart, A. L.
GUT, 2016, 65 : A252 - A253
[13] Clinical features of tuberculosis infection in inflammatory bowel disease patients on anti-TNF therapy
Estevez-Gil, M.
De Castro, M. L.
Hernandez, V.
Pineda, J. R.
Martinez-Cadilla, J.
Pereira, S.
Rodriguez-Prada, J-I
JOURNAL OF CROHNS & COLITIS, 2017, 11 : S309 - S309
[14] Diagnosis and treatement of latent tuberculosis infection in patients with chronic Inflammatory Bowel Disease candidates for anti-TNFα therapy in a tuberculosis endemic country
Mouslim, I
Jioua, C.
Touibi, A.
Ouahid, S.
Nejjari, F.
Berrag, S.
Tarik, A.
Mouna, T.
JOURNAL OF CROHNS & COLITIS, 2025, 19 : I1026 - I1026
[15] Safety of anti-TNF introduction following tuberculosis treatment in Inflammatory Bowel Disease patients in an endemic area
Azevedo, M. F. C. D.
Justus, F. F.
Lima, C. C. G.
Garcia, K. S.
Barros, L. L.
Oba, J.
Carlos, A. D. S.
Milani, L. R.
Sipahi, A. M.
Damiao, A. O. M. C.
Queiroz, N. S. F.
JOURNAL OF CROHNS & COLITIS, 2021, 15 : S445 - S445
[16] Optimization of anti-TNF therapy in patients with Inflammatory Bowel Disease
Strik, A. S.
Bots, S. J. A.
D'Haens, G.
Lowenberg, M.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2016, 9 (03) : 429 - 439
[17] Screening for TB in Hospitalised Patients with Inflammatory Bowel Disease before Anti-TNF Therapy: Is QuantiFERON(R) Gold Testing Useful?
Lovatt, Jessica
Gascoyne-Binzi, Deborah
Hussey, Thomas
Garside, Maya
McGill, Fiona
Selinger, Christian P.
JOURNAL OF CLINICAL MEDICINE, 2021, 10 (09)
[18] Endemic Fungal Infections in Inflammatory Bowel Disease Associated with Anti-TNF Antibody Therapy
Ordonez, Miguel E.
Farraye, Francis A.
Di Palma, Jack A.
INFLAMMATORY BOWEL DISEASES, 2013, 19 (11) : 2490 - 2500
[19] Physicians inconsistently perform tuberculosis screening in Inflammatory Bowel Disease patients managed with anti-TNF agents
Kenney, Adam
Jakhete, Neha
Gordon, Joseph A.
Watts, Kate
Borum, Marie L.
INFLAMMATORY BOWEL DISEASES, 2011, 17 : S45 - S45
[20] Screening for tuberculosis in Inflammatory Bowel Disease patients treated with immunosupressant medications versus Anti-TNF medications
Bornstein, L.
Sidhu, H.
Borum, M.
INFLAMMATORY BOWEL DISEASES, 2008, 14 (12) : S41 - S41

← 1 2 3 4 5 →